CIAM
APYX icon

Caitong International Asset Management’s Apyx Medical APYX Stock Holding History

Caitong International Asset Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135 Buy
30
+15
+100% +$59 ﹤0.01% 2098
2026
Q1 		$55 Buy
+15
New +$56 ﹤0.01% 2008

Other funds holding APYX

Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Horizon Kinetics Asset Management
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Caitong International Asset Management's APYX Position: Q2 2026 in Review

Caitong International Asset Management increased its Apyx Medical (APYX) stake by 100% in Q2 2026, buying an estimated $59 and bringing the position to 30 shares worth $135. The position accounts for ﹤0.01% of the portfolio, ranked #2098.

Caitong International Asset Management first reported a position in APYX in Q1 2026 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Caitong International Asset Management held 30 shares of Apyx Medical worth $135 as of Q2 2026.
  • Caitong International Asset Management bought 15 Apyx Medical shares in Q2 2026, an estimated $59.
  • Apyx Medical made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2098 holding.
  • Caitong International Asset Management first reported a position in Apyx Medical in Q1 2026 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.